October brought several updates in the lung cancer field, ranging from notable trial results to patient-centered perspectives ...
The latest national report of the American Lung Association 2025: State of Lung Cancer Report was published on Nov 5, 2025, ...
For individuals living with COPD, small changes may make a difference. Viatris Inc. and Theravance Biopharma US, Inc. COPD, or chronic obstructive pulmonary disease, is a group of life-changing lung ...
Triple therapy in COPD significantly improves lung function vs LAMA monotherapy, LABA/LAMA, and ICS/LABA, although evidence showing this is often low quality. Triple therapy is likely effective, safe, ...
A new report from the American Lung Association reveals that Georgia ranks among the worst states in the nation for lung ...
Lung cancer is the leading cause of cancer-related deaths in the United States. As we start Lung Cancer Awareness Month, a ...
Anti-IL5 therapy significantly reduces moderate and severe exacerbations in asthma and COPD, preventing major ...
Effective treatment often requires you to take medications to better manage symptoms or stop taking medications if a doctor advises that you no longer need them. Finding the right dosages and ...
Temple Health leads research showing how women and non-smokers face rising risks, and how new treatments are changing the ...
Angiotensin-converting enzyme (ACE) inhibitor therapy may reduce all-cause mortality in idiopathic pulmonary fibrosis (IPF) but not in COPD.
For individuals living with COPD, small changes may make a difference. Viatris Inc. and Theravance Biopharma US, Inc. COPD, or chronic obstructive pulmonary disease, is a group of life-changing lung ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback